Intraoperative awareness — the unexpected conscious experience during general anesthesia — affects approximately 1–2 patients per 1,000 anesthetic procedures and can cause significant psychological trauma including PTSD in 30% of those affected. Despite improvements in anesthetic technique and monitoring, awareness remains a recognized complication with both clinical and medicolegal significance. The bispectral index (BIS) monitor — quantifying anesthetic depth from EEG signals — was developed to reduce awareness risk but has generated mixed evidence in large clinical trials.
BIS Monitoring: Clinical Evidence
BIS values range 0 (no EEG activity) to 100 (fully awake). The recommended anesthetic depth target is BIS 40–60. The B-Aware trial (n=2,463) showed BIS-guided anesthesia reduced awareness incidence from 0.91% to 0.17% — a significant benefit. However, the larger B-Unaware trial (n=2,000) and BAG-RECALL trial (n=6,041) found NO significant benefit of BIS over end-tidal agent concentration (ETAC) monitoring in patients at high awareness risk. The consensus from systematic review: BIS monitoring is not superior to ETAC monitoring for awareness prevention in most surgical cases — but BIS adds value in: total IV anesthesia (TIVA, where no volatile agent concentration is available), patients with prior awareness, cardiac surgery cases, high neuromuscular blockade depth, and obese patients where pharmacokinetics are altered. Society recommendations (ASA 2011): offer brain function monitoring to high-risk patients; it is not required universally. For surgical facilities, our OR & Surgery catalog includes anesthesia supplies, electrode kits, and monitoring accessories.
